Suppr超能文献

骨转换生化标志物与影像学骨改变的相关性:来自骨关节炎倡议的数据。

Association Between Biochemical Markers of Bone Turnover and Bone Changes on Imaging: Data From the Osteoarthritis Initiative.

机构信息

Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia.

Duke University School of Medicine, Durham, North Carolina.

出版信息

Arthritis Care Res (Hoboken). 2017 Aug;69(8):1179-1191. doi: 10.1002/acr.23121. Epub 2017 Jul 10.

Abstract

OBJECTIVE

To determine the relationship between biochemical markers involved in bone turnover and bone features on imaging in knees with osteoarthritis (OA).

METHODS

We analyzed data from the Foundation for the National Institutes of Health OA Biomarkers Consortium within the Osteoarthritis Initiative (n = 600). Bone marrow lesions (BMLs), osteophytes, and subchondral bone area (mm ) and shape (position on 3-D vector) were assessed on magnetic resonance images, and bone trabecular integrity (BTI) was assessed on radiographs. Serum and urinary markers (serum C-terminal crosslinked telopeptide of type I collagen [CTX-I], serum crosslinked N-telopeptide of type I collagen [NTX-I], urinary NTX-I, urinary C-terminal crosslinked telopeptide of type II collagen [CTX-II], and urinary CTX-Iα and CTX-Iβ) were measured. The associations between biochemical and imaging markers at baseline and over 24 months were assessed using regression models adjusted for covariates.

RESULTS

At baseline, most biochemical markers were associated with BMLs, with C statistics for the presence/absence of any BML ranging from 0.675 to 0.688. At baseline, urinary CTX-II was the marker most consistently associated with BMLs (with odds of having ≥5 subregions affected compared to no BML increasing by 1.92-fold [95% confidence interval (95% CI) 1.25, 2.96] per 1 SD of urinary CTX-II), large osteophytes (odds ratio 1.39 [95% CI 1.10, 1.77]), bone area and shape (highest partial R  = 0.032), and changes in bone shape over 24 months (partial R range 0.008 to 0.024). Overall, biochemical markers were not predictive of changes in BMLs or osteophytes. Serum NTX-I was inversely associated with BTI of the vertical trabeculae (quadratic slope) in all analyses (highest partial R  = 0.028).

CONCLUSION

We found multiple significant associations, albeit mostly weak ones. The role of systemic biochemical markers as predictors of individual bone anatomic features of single knees is limited based on our findings.

摘要

目的

确定骨关节炎(OA)膝关节中涉及骨转换的生化标志物与影像学骨特征之间的关系。

方法

我们分析了国家卫生研究院 OA 生物标志物联盟基金会在骨关节炎倡议(OAI)中的数据(n=600)。在磁共振图像上评估骨髓病变(BML)、骨赘和软骨下骨面积(mm)和形状(3D 向量上的位置),并在 X 光片上评估骨小梁完整性(BTI)。测量血清和尿液标志物(血清 I 型胶原 C 端交联肽[CTX-I]、血清 I 型胶原交联 N 端肽[NTX-I]、尿 NTX-I、尿 II 型胶原 C 端交联肽[CTX-II]和尿 CTX-Iα和 CTX-Iβ)。使用调整协变量的回归模型评估基线和 24 个月时生化和影像学标志物之间的相关性。

结果

基线时,大多数生化标志物与 BML 相关,存在/不存在任何 BML 的 C 统计量范围为 0.675 至 0.688。基线时,尿 CTX-II 是与 BML 最一致相关的标志物(与无 BML 相比,每增加 1 个 SD 的尿 CTX-II,有≥5 个亚区受累的可能性增加 1.92 倍[95%置信区间(95%CI)1.25,2.96])、大骨赘(优势比 1.39[95%CI 1.10,1.77])、骨面积和形状(最高部分 R  = 0.032)以及 24 个月内骨形状的变化(部分 R 范围 0.008 至 0.024)。总体而言,生化标志物不能预测 BML 或骨赘的变化。血清 NTX-I 在所有分析中与垂直小梁的 BTI 呈负相关(最高部分 R  = 0.028)。

结论

我们发现了多个有意义的关联,尽管大多数关联都很微弱。根据我们的发现,系统生化标志物作为单个膝关节个体骨骼解剖特征预测因子的作用是有限的。

相似文献

1
Association Between Biochemical Markers of Bone Turnover and Bone Changes on Imaging: Data From the Osteoarthritis Initiative.
Arthritis Care Res (Hoboken). 2017 Aug;69(8):1179-1191. doi: 10.1002/acr.23121. Epub 2017 Jul 10.
5
Biochemical markers of bone turnover and their association with bone marrow lesions.
Arthritis Res Ther. 2008;10(4):R102. doi: 10.1186/ar2494. Epub 2008 Aug 29.

引用本文的文献

4
Neuropathic-like pain in knee osteoarthritis: exploring differences in knee loading and inflammation. A cross-sectional study.
Eur J Phys Rehabil Med. 2024 Feb;60(1):62-73. doi: 10.23736/S1973-9087.23.07877-2. Epub 2023 Nov 7.
5
Biomarkers for Osteoarthritis Diseases.
Life (Basel). 2022 Nov 7;12(11):1799. doi: 10.3390/life12111799.
6
Multivariable Modeling of Biomarker Data From the Phase I Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium.
Arthritis Care Res (Hoboken). 2022 Jul;74(7):1142-1153. doi: 10.1002/acr.24557. Epub 2022 May 3.
8
Clinically Relevant Molecular Biomarkers for Use in Human Knee Osteoarthritis: A Systematic Review.
Cartilage. 2021 Dec;13(1_suppl):1511S-1531S. doi: 10.1177/1947603520941239. Epub 2020 Jul 17.

本文引用的文献

1
Establishment of reference intervals for osteoarthritis-related soluble biomarkers: the FNIH/OARSI OA Biomarkers Consortium.
Ann Rheum Dis. 2017 Jan;76(1):179-185. doi: 10.1136/annrheumdis-2016-209253. Epub 2016 Jun 24.
2
Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.
Ann Rheum Dis. 2017 Jan;76(1):186-195. doi: 10.1136/annrheumdis-2016-209252. Epub 2016 Jun 13.
6
Subchondral bone and osteoarthritis.
Curr Opin Rheumatol. 2015 Jul;27(4):420-6. doi: 10.1097/BOR.0000000000000181.
9
Biomarkers for osteoarthritis: current position and steps towards further validation.
Best Pract Res Clin Rheumatol. 2014 Feb;28(1):61-71. doi: 10.1016/j.berh.2014.01.007.
10
The effect of type II collagen on MSC osteogenic differentiation and bone defect repair.
Biomaterials. 2014 Mar;35(9):2680-91. doi: 10.1016/j.biomaterials.2013.12.005. Epub 2014 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验